Cold and Flu Prevention: Fact vs. Fiction

SHARON ORRANGE, | January 8, 2020

article image
Cold and flu season is here. The common cold, often caused by rhinoviruses, is the most common human illness and comes with generally mild symptoms. The flu, caused by the influenza virus, can have more complicated symptoms. Both are contagious. So, what can you do to not get sick? That’s a question primary care doctors hear daily in the office. Let’s take a look at where the evidence lies. Perhaps the best-studied supplement for cold prevention is vitamin C. Unless you are a marathoner or heading to extremely cold temperatures, taking vitamin C has no more benefit than taking a placebo for the prevention of colds. I know. I’m sorry.

Spotlight

Arriello Group

We are a leading provider of Market Access Consultancy alongside Global and local Regulatory affairs and Pharmacovigilance. Headquartered in Ireland, with European operations in Central Europe, we provide expert Market Access guidance across the US, EU, LATAM, CIS, Asia and South Africa regions. With our extensive global vendor network, ISO 9001 certification, years of experience and satisfied clients, including global Originators, Biotech’s, Generics and CRO’s, no matter how complex or simple your requirements you can rely on us as a trusted partner.

OTHER ARTICLES

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Spotlight

Arriello Group

We are a leading provider of Market Access Consultancy alongside Global and local Regulatory affairs and Pharmacovigilance. Headquartered in Ireland, with European operations in Central Europe, we provide expert Market Access guidance across the US, EU, LATAM, CIS, Asia and South Africa regions. With our extensive global vendor network, ISO 9001 certification, years of experience and satisfied clients, including global Originators, Biotech’s, Generics and CRO’s, no matter how complex or simple your requirements you can rely on us as a trusted partner.

Events